Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc Azioni (PSTV) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	5.89% 1.313	1.24	1.854	0.506	0.151
Operating Expenses	15.19% 5.173	4.491	3.344	5.226	5.723
Interest Income/Expense	28.74% 0.062	0.087	0.112	0.134	0.159
Benefits Costs and Expenses	14.89% 5.123	4.459	3.336	5.311	5.809
Costs And Expenses	15.19% 5.173	4.491	3.344	5.226	5.723
Operating Income/Loss	18.73% -3.86	-3.251	-1.49	-4.72	-5.572
Nonoperating Income/Loss	56.25% 0.05	0.032	0.008	-0.085	-0.086
Income/Loss From Continuing Operations Before Tax	18.36% -3.81	-3.219	-1.482	-4.805	-5.658
Income/Loss From Continuing Operations After Tax	18.36% -3.81	-3.219	-1.482	-4.805	-5.658
Net Income/Loss	18.36% -3.81	-3.219	-1.482	-4.805	-5.658
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	85.96% 0.4527	3.2254	2.5094	34.80	2.4661
Diluted Average Shares	85.96% 0.4527	3.2254	2.5094	34.80	2.4661
Basic Earnings Per Share	30.00% -0.70	-1.00	-0.59	-0.14	-0.16
Diluted Earnings Per Share	30.00% -0.70	-1.00	-0.59	-0.14	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-